These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17330291)

  • 1. Glucocorticoid-related cardiovascular and cerebrovascular events in rheumatic diseases: myth or reality?
    Gonzalez-Gay MA
    Arthritis Rheum; 2007 Mar; 57(2):191-2. PubMed ID: 17330291
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantifying risks: the case between glucocorticoids and tuberculosis.
    Carmona L
    Arthritis Rheum; 2006 Feb; 55(1):1-2. PubMed ID: 16463392
    [No Abstract]   [Full Text] [Related]  

  • 3. Managing comorbidities in the rheumatic diseases: the new reality.
    Wang BW
    J Rheumatol; 2003 May; 30(5):899-901. PubMed ID: 12734877
    [No Abstract]   [Full Text] [Related]  

  • 4. The epidemiology of glucocorticoid-associated adverse events.
    McDonough AK; Curtis JR; Saag KG
    Curr Opin Rheumatol; 2008 Mar; 20(2):131-7. PubMed ID: 18349741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study.
    Pujades-Rodriguez M; Morgan AW; Cubbon RM; Wu J
    PLoS Med; 2020 Dec; 17(12):e1003432. PubMed ID: 33270649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-related risk of vertebral fracture during glucocorticoid treatment of collagen vascular diseases.
    Tatsuno I; Suzuki S; Yoshida T; Nagano H; Hashimoto N; Mayama T; Tanaka T; Sugiyama T
    J Rheumatol; 2011 Oct; 38(10):2270-2. PubMed ID: 21965698
    [No Abstract]   [Full Text] [Related]  

  • 7. [Increased risk of for cardiovascular events from high doses].
    Kreutzkamp B
    Med Monatsschr Pharm; 2005 Nov; 28(11):410-1. PubMed ID: 16309026
    [No Abstract]   [Full Text] [Related]  

  • 8. [Osteoporosis in rheumatic diseases: role of glucocrticoids (part I)].
    Nasonov EL; Skripnikova IA
    Klin Med (Mosk); 1997; 75(10):12-8. PubMed ID: 9490330
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular manifestations of rheumatologic diseases.
    Roman MJ; Salmon JE
    Circulation; 2007 Nov; 116(20):2346-55. PubMed ID: 17998471
    [No Abstract]   [Full Text] [Related]  

  • 10. [Side effects of glucocorticoid therapy and their prevention].
    Novikov IuI; Anokhin VN; Stulova MA
    Ter Arkh; 1974; 46(9):69-75. PubMed ID: 4548227
    [No Abstract]   [Full Text] [Related]  

  • 11. Developments in glucocorticoid therapy.
    Bijlsma JW; Saag KG; Buttgereit F; da Silva JA
    Rheum Dis Clin North Am; 2005 Feb; 31(1):1-17, vii. PubMed ID: 15639052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid-induced diabetes in rheumatologic patients.
    Angelopoulos TP; Tentolouris NK; Bertsias GK; Boumpas DT
    Clin Exp Rheumatol; 2014; 32(1):126-30. PubMed ID: 24143933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pay attention to glucocorticoid-induced osteoporosis in treatment of rheumatic diseases].
    Zhang X
    Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):357-8. PubMed ID: 18953939
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: what is the true direction of effect?
    Davis JM; Maradit-Kremers H; Gabriel SE
    J Rheumatol; 2005 Oct; 32(10):1856-62. PubMed ID: 16206334
    [No Abstract]   [Full Text] [Related]  

  • 15. [Homocysteine and rheumatic disease].
    Tinazzi I; Caramaschi P; Patuzzo G; Bambara LM; Biasi D
    Recenti Prog Med; 2007 Dec; 98(12):646-52. PubMed ID: 18369042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of glucocorticoids - clinical trials.
    Da Silva JA
    Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S99-103. PubMed ID: 22018193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frequency of side effects of glucocorticoid therapy in relation to the regimen for administering the hormonal preparations].
    Zaremba EF
    Vrach Delo; 1984 Nov; (11):60-3. PubMed ID: 6396947
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of vertebral fractures in children with chronic rheumatic diseases at risk for osteopenia.
    Nakhla M; Scuccimarri R; Duffy KN; Chédeville G; Campillo S; Duffy CM; Azouz EM; Shenouda N; Sharma AK; Rodd C
    J Pediatr; 2009 Mar; 154(3):438-43. PubMed ID: 18950793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New glucocorticoids on the horizon: repress, don't activate!
    Song IH; Gold R; Straub RH; Burmester GR; Buttgereit F
    J Rheumatol; 2005 Jul; 32(7):1199-1207. PubMed ID: 16041872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cortisone therapy during pregnancy in acute rheumatism and related problems II].
    Lukanov P
    Akush Ginekol (Sofiia); 1966; 5(5):349-54. PubMed ID: 5303000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.